Naoki Tanaka
R&D Division, 1-2-58 Hiromachi, Shinagawa Ku
Hiromachi, 1408710, Japan
Hiromachi, 1408710, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Discovery of DS79540454 via fragment-based drug discovery strategy: New scaffolds of hypoxia-inducible factor prolyl hydroxylase inhibitor.
Journal: Bioorganic & medicinal chemistry letters
Published: October 06, 2025
Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity.
Journal: Bioorganic & medicinal chemistry
Published: June 28, 2024
Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia.
Journal: Bioorganic & medicinal chemistry letters
Published: April 25, 2024
Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia.
Journal: Bioorganic & medicinal chemistry letters
Published: April 16, 2024
Effectiveness of warm-up and dynamic balance training in preventing anterior cruciate ligament injuries in college gymnasts: a 3-year prospective study for one team.
Journal: The Journal of sports medicine and physical fitness
Published: December 14, 2023
Influence of Robot-Assisted Gait Training on Lower-Limb Muscle Activity in Patients With Stroke: Comparison With Conventional Gait Training.
Journal: Annals of rehabilitation medicine
Published: December 01, 2022
Throwing kinematics and elbow varus torque relative to ball size in junior baseball players.
Journal: Journal of physical therapy science
Published: August 23, 2021
Influence of pitching grip on shoulder and elbow injuries in junior baseball players, focusing on hand length and the metacarpophalangeal joint angle.
Journal: Journal of physical therapy science
Published: April 19, 2021
Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay.
Journal: Biochemical and biophysical research communications
Published: August 04, 2018
Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: June 08, 2018
Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: August 03, 2017
Last Updated: 09/26/2026